MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Evaluation of Neurotransmitter and Co-transmitter Expression in the Aging Human Locus Coeruleus: Relevance to Neurodegenerative Disorders.

A. Bhattacharya, A. Mahadevan, R. Manjithaya, Y. Tc, P. Alladi (Bengaluru, India)

Meeting: 2024 International Congress

Abstract Number: 1875

Keywords: Aging, Parkinson’s, Pontine nuclei

Category: Other

Objective: To analyze the age-associated changes in the neurotransmitter/co-transmitter expression and morphometric profiles of human locus coeruleus (LC) neurons using autopsied human tissues.

Background: LC plays a significant role in both Parkinson’s disease (PD) and Alzheimer’s disease. As per the Braak staging of PD, LC pathology is associated with stage-2. Besides, the extent of pathology may differ in the individuals/populations prone to the disease. Earlier studies from our lab have reported preserved counts of melanized nigral neurons and sub-threshold neurodegeneration in the aging Asian Indians compared to the Caucasians. Therefore, the current study involves in-depth analysis of LC neurons.

Method: The tissues examined extended from the level of cerebral aqueduct to the full extent of the fourth ventricle. The number, volume and density of LC neurons were determined using the optical fractionator sampling design and nucleator probe using 40X magnification on a StereoInvestigator workstation (n=18). Every 20th section, (n= 8-14 sections; total 200-250 sections/specimen) were quantified along the rostro-caudal extent. Secondly, immunostaining for tyrosine hydroxylase (TH) and galanin (Gal) were performed on serial sections wherein, the neuronal clusters were split into medial (MED) and lateral (LAT) groups based on their proximity to the ventricle. The neuronal diameter and expression of enzyme/neuropeptide were assessed on high magnification images using a ‘Windows’ based image analysis system (n=13). Pearson’s correlation coefficient was used to assess the age-related changes.

Results: A significant reduction in the LC volume was observed on both sides (left, r=-.51; p=0.03), (right, r=-.52; p=0.02). No changes were seen in neuronal numbers based on size/pigmentation; and density per unit area. Further, no correlation was noted in both TH- and Gal expression with age.

Conclusion: Current findings of preserved neurotransmitter/co-transmitter expression and neuronal counts in the LC match well with the previous findings on the nigra of aging Asian Indians.  The volumetric decline with age may suggest sub-threshold changes. Further, analysis of protein aggregates and autophagy may provide vital leads for relevance of LC in neurodegeneration.

To cite this abstract in AMA style:

A. Bhattacharya, A. Mahadevan, R. Manjithaya, Y. Tc, P. Alladi. Evaluation of Neurotransmitter and Co-transmitter Expression in the Aging Human Locus Coeruleus: Relevance to Neurodegenerative Disorders. [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/evaluation-of-neurotransmitter-and-co-transmitter-expression-in-the-aging-human-locus-coeruleus-relevance-to-neurodegenerative-disorders/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/evaluation-of-neurotransmitter-and-co-transmitter-expression-in-the-aging-human-locus-coeruleus-relevance-to-neurodegenerative-disorders/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley